← All trials
NCT04519749
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2020
- Primary completion
- Feb 28, 2027
- Completion date
- Apr 30, 2027
- First posted
- Aug 20, 2020
- Last posted
- Dec 8, 2020
- Enrollment
- 18
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- 4D Molecular TherapeuticsLead sponsor
- 4D Molecular TherapeuticsStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.